Li-Fraumeni Syndrome - 25 Studies Found Not yet recruiting : Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion : Malignant Pleural Effusion : 2015-04-24 : Drug: rAdp53 Recombinant adeno Not yet recruiting : rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors : Advanced Malignant Thyroid Tumors : 2009-05-12 : Drug: rAd-p53 gene pre-surgery Not yet recruiting : The p53 Colorectal Cancer Trial : Colorectal Cancer Metastatic Colorectal Cancer Stage IV : 2017-03-14 : Drug: Cyclophosphamide Chemotherapy Other Name: Send Not yet recruiting : p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma : HCC Diabetes : 2015-09-11 : Drug: p53 gene therapy Trans-c Not yet recruiting : P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer : Advanced Head and Neck Cancer : 2015-04-20 : Drug: rAd-p53 multi-point inje Recruiting : Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma : Advanced Hepatocellular Carcinoma (HCC) : 2015-07-19 : Drug: TAE plus P53 gene Trans- Recruiting : Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma : Advanced Adult Hepatocellular Carcinoma : 2015-03-25 : Drug: TACE plus rAd-p53 artery injection Recruiting : Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt : Advanced Solid and Hematological TP53wt Tumors : 2014-05-19 : Drug: HDM201 Drug: ancillary treatment Not yet recruiting : p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer : Ovarian Epithelial Cancer Fallopian Tube Cancer Primary Pe : 2015-04-28 : Drug: p53 gene p53 gene will b Recruiting : A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor : Chronic Lymphocytic Leukemia (CLL) : 2016-11-30 : Drug: Venetoclax Tablet Other Name: ABT-199 <<< Previous | Next >>>